The “Aeterna”, a new COVID variant, is making steady advancement to fuel a new wave.
While the once-feared Omicron sub-variant BA fades into the sunset, one of its successors is
Zynerba receives Patent for Fragile X Drug
Devon, PA, Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies
Cytiva strengthens cell line development with CEVEC acquisition
Viral vector manufacturing and cell line development are keystone technologies in the making of
Pfizer invested $120 million in Resapp-An app that detects COVID by simply listening to someone’s cough.
Pharmaceutical giant Pfizer has paid nearly $120 million to buy a small Australian company that
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
NEW BRUNSWICK, N.J. September 28, 2022 — Johnson & Johnson (the “Company”) (NYSE: JNJ) today took
Biogen Inc. agreed to pay $900 million to settle allegations over alleged improper physician payments.
The Justice Department announced Monday that Biogen Inc. agreed to pay $900 million to settle
The Fascinating Science of Clinical Trials
What are clinical trials? Clinical trials are designed to determine whether a medical, surgical, or
Is cancer under 50 the new normal global epidemic?
Cancer is becoming more and more of a tragedy in our world. The American Cancer
Loses might touch$100bn-3M bankruptcy and Earplug Lawsuit case.
3M moved the main battle of the approved fight to court in an attempt to